COMP <GO>
NHC vs JNJ // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
National HealthCare Corporation (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: NHC 4
— JNJ 7
■ METRIC PARITY
LAST: $212.16 (+0.18%) • MKT CAP: $3.32B
options-implied-move
—
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NHC VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NHC | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 67.90% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.10% | 25.50% | -15.40 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 20.5x | 18.5x | +2.00 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | 4.47% | 2.97% | +1.50 | NHC | /fcf-yield <GO> |
| Operating Margin | 8.50% | 34.70% | -26.20 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 7.90% | 28.50% | -20.60 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 16.10% | 6.00% | +10.10 | NHC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.16% | 0.00% | +1.16 | NHC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.61 | 5.59 | +1.02 | NHC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.1 | 62.1 | -27.00 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.3x | 23.0x | +0.30 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.32B | $662.49B | -$659.17B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NHC REV | JNJ REV | NHC GROSS % | JNJ GROSS % | NHC FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.52B | $94.19B | — | 67.9% | $148.6M | $19.70B |
| FY 2024 | $1.31B | $88.82B | — | 69.1% | $79.7M | $19.84B |
| FY 2023 | $1.14B | $85.16B | — | — | $111.2M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NHC // BETA —
JNJ // BETA 1.08